Skip to main content
. 2024 Jul 9;24(3):100483. doi: 10.1016/j.ijchp.2024.100483

Table 1.

Participant demographics, comparisons of mood scale and cognitive function between BLT and placebo.

BLT Placebo t/x2 p FDR-p
Number of participants 55 51
Sex (male/female) 21/34 16/35 0.540 0.462
Age (years) 23.02 (2.17) 22.78 (2.26) 0.543 0.588a
Education (years) 16.80 (1.98) 16.76 (1.89) 0.094 0.925a
Mood scales
Baseline HDRS 14.25 (3.96) 15.49 (4.13) −1.573 0.119a 0.238
Baseline CESD 26.33 (9.05) 27.90 (9.39) −0.859 0.392a 0.438
Baseline PANAS-P 19.39 (4.45) 20.04 (3.93) −0.779 0.438a 0.438
Baseline PANAS-N 23.31 (5.54) 25.43 (5.26) −1.979 0.051a 0.204
Post-treatment HDRS 6.49 (4.27) 10.86 (7.00) −3.847 < 0.001a,*** < 0.001⁎⁎⁎
Post-treatment CESD 14.16 (9.14) 21.04 (10.06) −3.687 < 0.001a, *** < 0.001⁎⁎⁎
Post-treatment PANAS-P 22.80 (5.54) 22.39 (5.16) 0.386 0.700a 0.700
Post-treatment PANAS-N 17.81 (4.67) 22.65 (5.57) −4.794 < 0.001a,*** < 0.001⁎⁎⁎
Change in HDRS 7.75 (5.05) 4.69 (5.46) 2.997 0.003a,** 0.015*
Change in CESD 12.25 (12.72) 6.86 (10.70) 2.317 0.023a,* 0.038*
Change in PANAS-P −3.42 (5.53) −2.22 (4.99) −1.128 0.262a 0.262
Change in PANAS-N 5.58 (6.23) 2.80 (6.31) 2.208 0.030a,* 0.038*
Cognitive function
Baseline processing speed 50.78 (7.79) 51.67 (6.24) −0.643 0.522a 0.835
Baseline attention/vigilance 50.40 (6.92) 52.04 (6.83) −1.219 0.226a 0.603
Baseline working memory 47.19 (9.71) 46.86 (8.66) 0.179 0.858a 0.858
Baseline verbal learning 49.98 (7.39) 51.78 (6.20) −1.345 0.182a 0.603
Baseline visual learning 53.98 (6.50) 54.27 (5.12) −0.256 0.799a 0.858
Baseline reasoning problem-solving 53.80 (7.33) 51.49 (9.76) 1.363 0.176a 0.603
Baseline social cognition 45.31 (10.21) 43.92 (11.09) 0.670 0.504a 0.835
Baseline composite 50.08 (6.42) 50.41 (5.83) −0.277 0.782a 0.858
Post-treatment processing speed 55.53 (7.22) 56.73 (6.10) −0.912 0.364a 0.582
Post-treatment attention/vigilance 54.72 (7.33) 53.63 (7.41) 0.754 0.453a 0.604
Post-treatment working memory 48.81 (9.28) 50.73 (6.98) −1.185 0.239a 0.478
Post-treatment verbal learning 51.68 (5.69) 53.76 (6.31) −1.770 0.080a 0.320
Post-treatment visual learning 56.91 (4.91) 57.33 (4.44) −0.465 0.643a 0.735
Post-treatment reasoning problem-solving 57.13 (6.20) 53.41 (8.02) 2.639 0.010a, * 0.080
Post-treatment social cognition 46.79 (10.60) 43.42 (11.21) 1.559 0.122a 0.325
Post-treatment composite 54.54 (5.92) 54.22 (5.12) 0.290 0.772a 0.772
Change in processing speed 4.85 (6.18) 5.06 (4.85) −0.194 0.847a 0.950
Change in attention/vigilance 4.27 (5.45) 1.59 (5.12) 2.567 0.012a, * 0.096
Change in working memory 1.38 (9.06) 3.86 (7.19) −1.540 0.127a 0.508
Change in verbal learning 1.78 (6.75) 1.98 (6.46) −0.150 0.881a 0.950
Change in visual learning 2.98 (6.50) 3.06 (6.01) −0.063 0.950a 0.950
Change in reasoning problem-solving 3.27 (6.51) 1.92 (5.65) 1.121 0.265a 0.707
Change in social cognition 1.51 (9.82) −0.12 (9.17) 0.862 0.391a 0.782
Change in composite 4.31 (5.05) 3.80 (4.22) 0.542 0.589a 0.942

Mean (with standard deviation in parentheses) are reported unless otherwise noted. BLT, bright light therapy; HDRS, Hamilton Depression Rating Scale; CESD, Centre for Epidemiologic Studies Depression Scale; PANAS, Positive and Negative Affect Scale; FDR, false discovery rate. †, The p value for gender distribution was obtained by chi-square test. a, the p values were obtained by independent-sample t-tests. *, p < 0.05, **, p < 0.01, ***, p < 0.001.